Balchem Corporation (BCPC)

Balchem Corporation is a common stock listing on NASDAQ for a company that develops, manufactures, and distributes specialty performance ingredients and products used in nutrition, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial applications. The company operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Its Human Nutrition and Health business supplies ingredients for food and beverage applications, including spray dried and emulsified powders, flavor delivery systems, dairy and juice bases, and specialized vitamin and mineral ingredients. The Animal Nutrition and Health segment provides nutrient technologies for production and companion animals. The Specialty Products segment includes sterilization-related chemicals and equipment, propylene oxide, and chelated minerals for crops. Balchem was incorporated in 1967 and is headquartered in Montvale, New Jersey.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-BCPC
$164.64
-7.0% Downside
Fair
$209.25
18.2% Upside
Undervalued
Great
December 31, 2026
January 15, 2027
0.2%
February 19, 2027
33.0x
4.3x
5.1x
5.642 B
5.746 B
2.9%
14.0
18.7%
104.2%
Valuation • Fair Value

Balchem Corporation (NASDAQ-BCPC) Fair Value by Valuation Model

Review the available estimates for Balchem Corporation (NASDAQ-BCPC), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$164.64

Estimated downside of 7.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$166.79

Discounted cash flow valuation reference.

Ben Graham Formula Value

$57.23

Classic Ben Graham valuation formula reference.

DDM Fair Value

$143.53

Dividend discount model valuation reference.

Comps Fair Value

$169.52

Comparable-company valuation reference.

Analyst Price Target

$209.25

Analysts imply upside of 18.2%.

How to read these valuation models

Use the 7 available valuation references for Balchem Corporation (NASDAQ-BCPC) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Balchem Corporation (NASDAQ-BCPC)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.109 B

Current operating scale indicator.

Revenue Forecast

1.131 B

Forward revenue estimate.

EBITDA

278.1 M

Current operating profitability reference.

EBITDA Forecast

306.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Balchem Corporation (NASDAQ-BCPC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Balchem Corporation (NASDAQ-BCPC)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

9

Relatively strong quality score.

Beneish M-Score

-2.54

No elevated caution signal from this screen.

Altman Z-Score

14.0

Relatively strong balance-sheet zone.

FCF / Net Income

104.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Balchem Corporation (NASDAQ-BCPC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Balchem Corporation (NASDAQ-BCPC)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 19, 2027

Days to Earnings

118

Dividend Payment Date

January 15, 2027

Ex-Dividend Date

December 31, 2026

Dividend Yield

0.2%

Current income yield reference.

Payout Ratio

18.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Balchem Corporation (NASDAQ-BCPC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Balchem Corporation (NASDAQ-BCPC) Stock Forecast & Technical Outlook

Review Balchem Corporation (NASDAQ-BCPC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Balchem Corporation (NASDAQ-BCPC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Balchem Corporation (NASDAQ-BCPC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Balchem Corporation (NASDAQ-BCPC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Balchem Corporation (NASDAQ-BCPC) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Balchem Corporation (NASDAQ-BCPC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Balchem Corporation (NASDAQ-BCPC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Balchem Corporation (NASDAQ-BCPC) has a Buy consensus, with 1 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 1
Sell 0
FAQ • Fast Investor Answers

Balchem Corporation (NASDAQ-BCPC) Stock FAQ

Data-supported answers about Balchem Corporation (NASDAQ-BCPC), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$164.64
Estimated downside 7.0%
Valuation Rating
Overvalued
Estimated downside of 7.0%
Analyst Target
$209.25
Implied upside 18.2%
Financial Health
Great
Current financial-health read

The current fair value estimate for Balchem Corporation (NASDAQ-BCPC) is $164.64. This implies an estimated downside of 7.0% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 7.0% versus the current market price.

The available analyst price target for Balchem Corporation (NASDAQ-BCPC) is $209.25. The analyst target implies estimated upside of 18.2%.

The current financial health read for Balchem Corporation (NASDAQ-BCPC) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Balchem Corporation (NASDAQ-BCPC) is February 19, 2027.

Based on the current data, dividend yield is 0.2%, ex-dividend date is December 31, 2026, payment date is January 15, 2027.

The current P/E ratio listed for Balchem Corporation (NASDAQ-BCPC) is 33.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Balchem Corporation is 5.642 B.

The current enterprise value listed for Balchem Corporation is 5.746 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Balchem Corporation is NASDAQ-BCPC, and the stock is listed on NASDAQ.

Balchem Corporation (NASDAQ-BCPC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Balchem Corporation is 2.9%, which helps investors evaluate the company’s financing structure and leverage profile.